Rejuvesol Solution
Product Images NDC 23731-7000

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rejuvesol (NDC 23731-7000). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Citra Labs, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (50 mL Vial Label)

Rejuvesol red blood cell processing solution 50 mL vial label showing multiple active ingredients with strengths per 50 mL including Sodium Pyruvate, Inosine, Adenine, and Sodium Phosphates. Label includes manufacturer details for Citra Labs, LLC and Grand River Aseptic Manufacturing, along with storage instructions and regulatory markings. Not for direct patient administration, for extracorporeal use only.*

FDA Label Image

Principal Display Panel (50 mL Vial Case Label)

Label for Rejuvesol red blood cell processing solution in a 50 mL vial with a quantity of 12. Manufactured for Citra Labs, LLC, Braintree, MA, and manufactured by Grand River Aseptic Manufacturing, Grand Rapids, MI. The label includes storage instructions to protect from freezing and keep between 15°C and 25°C (59°F - 77°F). Contact phone and fax numbers for Citra Labs are provided, along with handling and sterile symbols and placeholders for lot number and expiration date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.